A Study Comparing the Differences Between Young and Non-young Breast Cancer

NCT06793306 | Enrolling By Invitation

• 1 other identifier: NCC5093
• Study Type: observational
• Target: 3,000
• Locations: 1 country
• Sites: 1

Brief Summary

To collect data on diagnosis, treatment, survival prognosis, and intrinsic molecular detection of breast cancer in China from January 2000 to December 2024.Compare the difference between young and non-young breast cancer.

Conditions

Breast Cancer

Outcome Measures

Primary Outcomes (1)

• Overall survival rate

  10-year

Secondary Outcomes (1)

• invasive disease-free survival rate

  10-year

Study Arms (1)

Breast cancer

Other: Age; Other: combination therapy

Interventions

Age OTHER

Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35

Breast cancer

combination therapy OTHER

To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer

Breast cancer

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

During the period from January 2000 to December 2024, the first breast cancer diagnosed and treated in several hospitals in China was in the age range of 18-75 years. Young patients with breast cancer were defined as ≤35 years old, and non-young patients were defined as patients over 35 years old.

You may qualify if:

• During the period from January 2000 to December 2024, the first breast cancer diagnosed and treated in several hospitals in China was in the age range of 18-75 years.

You may not qualify if:

• Breast cancer patients under 18 years of age or over 75 years of age; Combined with other malignant tumors; Patients with chronic infectious diseases or chronic infectious diseases; Patients with severe comorbidities, with serious dysfunction of vital organs (heart, liver, kidney); Known history of human immunodeficiency virus; The investigator concluded that patients should not be included in other conditions of this trial.

Sponsors & Collaborators

• Cancer Institute and Hospital, Chinese Academy of Medical Sciences: lead

Study Sites (1)

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Aging; Combined Modality Therapy

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Growth and Development; Physiological Phenomena; Therapeutics

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head of department

Study Record Dates

• First Submitted: January 18, 2025
• First Posted: January 27, 2025
• Study Start: January 1, 2025
• Primary Completion (Estimated): January 1, 2030
• Study Completion (Estimated): January 1, 2030
• Last Updated: February 14, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)